Melomind Revenue and Competitors
Estimated Revenue & Valuation
- Melomind's estimated annual revenue is currently $7.8M per year.
- Melomind's estimated revenue per employee is $216,000
Employee Data
- Melomind has 36 Employees.
- Melomind grew their employee count by -12% last year.
Melomind's People
Name | Title | Email/Phone |
---|
Melomind Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $21.9M | 81 | 9% | N/A | N/A |
#2 | $26.5M | 98 | -20% | N/A | N/A |
#3 | $46.6M | 157 | 23% | N/A | N/A |
#4 | $59.4M | 200 | 9% | N/A | N/A |
#5 | $37M | 137 | 29% | N/A | N/A |
#6 | $47.8M | 161 | 8% | N/A | N/A |
#7 | $56.4M | 190 | 3% | N/A | N/A |
#8 | $16.3M | 67 | -1% | N/A | N/A |
#9 | $4.3M | 23 | 5% | N/A | N/A |
#10 | $1.8M | 11 | -15% | N/A | N/A |
What Is Melomind?
myBrainTechnologies is an innovative start-up company located in Paris, France. Co-founded by neuroscientists Dr. Yohan Attal (PhD in brain imaging) and in collaboration with the Brain and Spine Institute (Pitié-Salpetrière Hospital). We aim to change the global technology of EEG (electroencephalogram) by taking it out of the research laboratories and providing it to the public market. We have developed products and applications based on brain activity, neuroscience and improving mental health. Our main product is Melomind, the first antistress brain-training solution based on neurofeedback that is accessible to the public. myBrain Technologies has revolutionized brain training, by making it accessible since its launch in 2013.
keywords:N/AN/A
Total Funding
36
Number of Employees
$7.8M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Melomind News
Melomind ? IMEC ? Mindo ? Wearable Sensing ? CUSOFT ? Mattel ? Macrotellect ? Neorowear. Consumer Level EEG Device Market Scope:.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.2M | 36 | -83% | N/A |
#2 | $4.2M | 36 | N/A | N/A |
#3 | $7.3M | 36 | 13% | N/A |
#4 | N/A | 36 | 0% | N/A |
#5 | $3.7M | 36 | 3% | N/A |